In focus · trending topic

Regulatory Pathway to Approval

2 stories · following the connections

Esperion Announces FDA Confirmation of Regulatory Pathway to Approval for the Combination of Bempedoic Acid and Ezetimibe

By Nasdaq OMXJun 26, 2017, 8:05 PM UTC

Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic Acid

By Nasdaq OMXMar 20, 2017, 11:30 AM UTC